Abstract
<i>Background/Aims:</i> Neutral endopeptidase (NEP) inhibition attenuates renal damage in the diabetic kidney, but little is known about the mechanisms of this renoprotective effect. <i>Methods:</i> We examined the interaction between angiotensin II (Ang II) and atrial natriuretic peptide (ANP) under low (5 m<i>M</i>) and high (30 m<i>M</i>) glucose conditions, on cell proliferation and extracellular matrix (ECM) synthesis in renomedullary interstitial cells (RMICs) derived from wild-type (WT) and NEP-deficient (NEP<sup>–</sup>) mice. <i>Results:</i> Under high glucose conditions, Ang II (10<sup>–6</sup><i>M</i>) increased cell proliferation (control, 174.3 ± 16.9; Ang II, 846.3 ± 91.0 cpm/well) and ECM synthesis (control, 22.3 ± 3.1; Ang II, 79.0 ± 9.6 cpm/cell) in RMICs derived from WT and NEP<sup>–</sup> mice to a similar extent. ANP (10<sup>–7</sup><i>M</i>) reduced Ang II-induced cell proliferation and ECM synthesis in RMICs derived from both strains, but more efficiently in RMICs derived from NEP<sup>–</sup>mice. The Ang II-induced cell proliferation and ECM synthesis was attenuated with AT<sub>1</sub> receptor blockade, but more efficiently in RMICs-derived NEP<sup>–</sup> mice. <i>Conclusions:</i> This data shows that ANP and AT<sub>1</sub> receptor blockade attenuate Ang II-induced RMIC proliferation and ECM synthesis more efficiently in the absence of NEP. These results support the concept that NEP inhibition is beneficial in attenuating abnormal cell growth and ECM metabolism associated with diabetic nephropathy.
Keywords
Affiliated Institutions
Related Publications
Molecular Dynamics Simulations of Angiotensin II in Aqueous and Dimethyl Sulfoxide Environments
Angiotensin II (Ang II) is an octapeptidic hormone, which plays an important role in the mechanisms of blood pressure control. In this work, extensive molecular dynamics (MD) si...
Angiotensin-converting enzyme inhibitor and spironolactone combination therapy
Secondary aldosteronism has deleterious effects in patients with congestive heart failure (CHF) and can contribute to congestion, ventricular arrhythmias, and sudden death. Mort...
Antihypertensive Therapy with MK 4211
Nineteen hypertensive patients were treated with increasing doses of the new angiotensin-converting enzyme inhibitor MK 421. Twenty milligrams orally reduced blood pressure from...
Evidence of a Partial Escape of Renin‐Angiotensin‐Aldosterone Blockade in Patients with Acute Myocardial Infarction Treated with Ace Inhibitors
Angiotensin‐Converting enzyme (ACE) inhibitors have been designed to block the renin‐angiotensin system and can represent an effective therapeutic approach in those settings whe...
?Escape? of aldosterone production in patients with left ventricular dysfunction treated with an angiotensin converting enzyme inhibitor: Implications for therapy
Despite the findings in randomized trials of a significant effect of angiotensin-converting enzyme (ACE) inhibitors in reducing morbidity and mortality of patients with symptoma...
Publication Info
- Year
- 2006
- Type
- article
- Volume
- 103
- Issue
- 3
- Pages
- p149-p156
- Citations
- 48
- Access
- Closed
External Links
Social Impact
Social media, news, blog, policy document mentions
Citation Metrics
Cite This
Identifiers
- DOI
- 10.1159/000092457